Patents by Inventor Martin Joseph Cummins

Martin Joseph Cummins has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF THROMBOCYTOPENIA USING ORALLY ADMINISTERED INTERFERON
    Publication number: 20170354715
    Abstract: An interferon composition is provided for enhancing the platelet count, reducing the recurrence rate of hepatitis, and/or improving the social function of hepatitis patients. The method comprises administering a low dose of IFN (about 5 IU to about 2500 IU of IFN-alpha) to a patient in need thereof. In one embodiment the IFN is alpha IFN or beta IFN, and more particularly, in one embodiment the administered biologically active IFN is human alpha IFN.
    Type: Application
    Filed: August 3, 2017
    Publication date: December 14, 2017
    Inventors: Martin Joseph CUMMINS, Chau-Ting YEH, Ching-Yuan LEE
  • Treatment of thrombocytopenia using orally administered interferon
    Patent number: 9839672
    Abstract: An interferon composition is provided for enhancing the platelet count, reducing the recurrence rate of hepatitis, and/or improving the social function of hepatitis patients. The method comprises administering a low dose of IFN (about 5 IU to about 2500 IU of IFN-alpha) to a patient in need thereof. In one embodiment the IFN is alpha IFN or beta IFN, and more particularly, in one embodiment the administered biologically active IFN is human alpha IFN.
    Type: Grant
    Filed: August 3, 2017
    Date of Patent: December 12, 2017
    Assignee: Amarillo Biosciences, Inc.
    Inventors: Martin Joseph Cummins, Chau-Ting Yeh, Ching-Yuan Lee
  • Treatment of thrombocytopenia using orally administered interferon
    Patent number: 9750786
    Abstract: An interferon composition is provided for enhancing the platelet count, reducing the recurrence rate of hepatitis, and/or improving the social function of hepatitis patients. The method comprises administering a low dose of IFN (about 5 IU to about 2500 IU of IFN-alpha) to a patient in need thereof. In one embodiment the IFN is alpha IFN or beta IFN, and more particularly, in one embodiment the administered biologically active IFN is human alpha IFN.
    Type: Grant
    Filed: October 31, 2016
    Date of Patent: September 5, 2017
    Assignee: Amarillo Biosciences, Inc.
    Inventors: Martin Joseph Cummins, Chau-Ting Yeh, Ching-Yuan Lee
  • TREATMENT OF THROMBOCYTOPENIA USING ORALLY ADMINISTERED INTERFERON
    Publication number: 20170042974
    Abstract: An interferon composition is provided for enhancing the platelet count, reducing the recurrence rate of hepatitis, and/or improving the social function of hepatitis patients. The method comprises administering a low dose of IFN (about 5 IU to about 2500 IU of IFN-alpha) to a patient in need thereof. In one embodiment the IFN is alpha IFN or beta IFN, and more particularly, in one embodiment the administered biologically active IFN is human alpha IFN.
    Type: Application
    Filed: October 31, 2016
    Publication date: February 16, 2017
    Inventors: Martin Joseph CUMMINS, Chau-Ting YEH, Ching-Yuan LEE
  • Treatment of thrombocytopenia using orally administered interferon
    Patent number: 9526694
    Abstract: An interferon composition is provided for enhancing the platelet count, reducing the recurrence rate of hepatitis, and/or improving the social function of hepatitis patients. The method comprises administering a low dose of IFN (about 5 IU to about 2500 IU of IFN-alpha) to a patient in need thereof. In one embodiment the IFN is alpha IFN or beta IFN, and more particularly, in one embodiment the administered biologically active IFN is human alpha IFN.
    Type: Grant
    Filed: April 30, 2013
    Date of Patent: December 27, 2016
    Assignee: Amarillo Biosciences, Inc.
    Inventors: Martin Joseph Cummins, Chau-Ting Yeh, Ching-Yuan Lee
  • TREATMENT OF THROMBOCYTOPENIA USING ORALLY ADMINISTERED INTERFERON
    Publication number: 20150132261
    Abstract: An interferon composition is provided for enhancing the platelet count, reducing the recurrence rate of hepatitis, and/or improving the social function of hepatitis patients. The method comprises administering a low dose of IFN (about 5 IU to about 2500 IU of IFN-alpha) to a patient in need thereof. In one embodiment the IFN is alpha IFN or beta IFN, and more particularly, in one embodiment the administered biologically active IFN is human alpha IFN.
    Type: Application
    Filed: April 30, 2013
    Publication date: May 14, 2015
    Inventors: Martin Joseph Cummins, Chau-Ting Yeh, Ching-Yuan Lee